In all of these studies correlating OPN levels with outcomes in cancer and other diseases, the assays used to measure OPN levels in blood or tumor biopsies were commercial ELISAs that neither distinguish between the different splice forms of intact OPN-FL nor between the different proteolytically cleaved fragments of OPN. The gene discussed is SPP1; the disease is cancer.